Pre-order of India's 160 crore Corona vaccine dose; Will cover 60% of the population

In the war against Coronavirus, China has given emergency approval to 4, Russia 2 and UK 1 vaccine. Even though the vaccine has not received approval in India, it is at the forefront of pre-orders. According to a global analysis, India has secured 160 crore doses. Experts are saying that it will cover 80 crore people i.e. 60% of our country's population. This will be enough to develop herd immunity.

According to the Launch and Scale Speedometer Analysis, which is updated every two weeks, India has secured 160 crore doses of these three vaccines by 30 November. At the same time, after that, the European Union has secured Dose 158 Crores and America has a little more than 100 Crores. According to America's Duke University Global Health Innovation Center, India has signed an agreement to buy 500 million doses of the Kovyshield vaccine at Oxford University-AstraZeneca. At the same time, India is going to get 100 crore doses from American company Novavax and 100 million doses of Sputnik V vaccine from Russia's Gamalaya Research Institute. Duke researchers said in the analysis that countries with manufacturing potential, such as India and Brazil, have gained a large number of market commitments from major vaccine candidates. That too before these candidates came to the vaccine market.

Poor countries completely dependent on WHO

According to Duke University's report, high-income countries have secured 380 million doses. Upper middle-income countries have secured 82.9 million doses and lower-middle-income countries have achieved 170 million doses. Researchers say that low-income countries have not made any direct deals. That is, 20% of the population is completely dependent on Kovacs. COVAX is an initiative of the World Health Organization, the Coalition for Endemic Preparedness Innovations (CEPI), and the International Vaccine Alliance Organization Gavi, which aims to make the COVID-19 vaccine available to governments and vaccine manufacturers as well as all countries.

Vaccine order up to five times the population

According to an analysis by Global Researchers, many countries have booked pre-orders for more vaccines than their population. Canada has booked 527% more vaccines than its population, while the UK has pre-booked 288%, Australia 266%, Chile 223%, European Union 199%, USA 169%, and Japan 115%. The reason for doing this is that even if a vaccine failed and could not reach the approval stage, the population should not be deprived of the vaccine. At the same time, the vaccine is seen reaching 60% of the population in India.

Vaccines should not be the authority of only a few rich countries

Experts working in the field of public health have urged leaders from all over the world to understand the responsibility for Covid-19 as well as future diseases. So that the right to treatment or vaccine of Covid-19 will not remain with only a few selected rich countries. 400 other Institutions led by George Institute for Global Health in India have jointly requested this to global leaders. It also includes the Public Health and Social Justice Department of Jawaharlal Nehru University. Kamna Kakkar, MD in Anesthesiology and Critical Care at PGIMS Rohtak said that according to news reports, 70% of the vaccine has been asserted by rich and rich countries. Every country is trying to get more and more vaccines for its population. In such a situation, what will happen to those countries that cannot afford the vaccine?

Hyderabad and Delhi airports also ready for vaccine transportation

Air cargo services at Delhi and Hyderabad airports are fully ready for vaccine distribution. Delhi Airport has two cargo terminals. These state-of-the-art time and temperature-sensitive distribution systems will play a special role in the distribution of the vaccine. Delhi Airport can handle 1.5 lakh metric tonnes of cargo annually. It has temperature-controlled zones ranging from -20 ° to 25 ° C. GMR Hyderabad Air Cargo holds a special place not only in the country but also in global vaccine logistics. A Hyderabad airport spokesperson said that GMR Hyderabad Air Cargo is the first pharma zone in India to have a GDP-certified temperature-controlled facility.